Aibotics, Inc. (AIBT)
0.0005
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
Aibotics Total Liabilities (Quarterly) : 5.152M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.152M |
| March 31, 2026 | 5.051M |
| December 31, 2025 | 4.835M |
| September 30, 2025 | 4.903M |
| June 30, 2025 | 5.394M |
| March 31, 2025 | 5.101M |
| December 31, 2024 | 4.852M |
| September 30, 2024 | 5.002M |
| June 30, 2024 | 4.813M |
| March 31, 2024 | 4.599M |
| December 31, 2023 | 4.248M |
| September 30, 2023 | 2.055M |
| June 30, 2023 | 1.768M |
| March 31, 2023 | 1.553M |
| December 31, 2022 | 1.279M |
| September 30, 2022 | 0.8914M |
| June 30, 2022 | 0.9445M |
| March 31, 2022 | 1.319M |
| Date | Value |
|---|---|
| December 31, 2021 | 1.218M |
| September 30, 2021 | 0.7162M |
| June 30, 2021 | 0.6458M |
| March 31, 2021 | 0.1275M |
| December 31, 2020 | 0.127M |
| September 30, 2020 | 0.0011M |
| June 30, 2020 | 0.0108M |
| March 31, 2020 | 0.0005M |
| December 31, 2019 | |
| September 30, 2019 | 0.7664M |
| June 30, 2019 | 1.456M |
| March 31, 2019 | 1.103M |
| December 31, 2018 | 0.8529M |
| September 30, 2018 | 0.934M |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 0.9087M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| CS Diagnostics Corp. | 0.0153M |
| GeneDx Holdings Corp. | 237.26M |
| Ayujoy Herbals Ltd. | -- |
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.5496M |
| Shareholders Equity (Quarterly) | -4.602M |
| Debt to Equity Ratio | -0.2804 |
| Current Ratio | 0.0535 |
| Net Debt Paydown Yield | -1.17% |